Trevena Inc (TRVN)
1.81
-0.16
(-7.89%)
USD |
OTCM |
Nov 08, 14:31
Trevena Revenue (Annual): 3.125M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.125M |
| December 31, 2022 | -0.418M |
| December 31, 2021 | 0.567M |
| December 31, 2020 | 3.069M |
| December 31, 2019 | 0.031M |
| December 31, 2018 | 5.732M |
| December 31, 2017 |
| Date | Value |
|---|---|
| December 31, 2016 | 3.75M |
| December 31, 2015 | 6.25M |
| December 31, 2014 | |
| December 31, 2013 | 0.135M |
| December 31, 2012 | 0.8076M |
| December 31, 2011 | 2.421M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
-0.418M
Minimum
2022
3.125M
Maximum
2023
1.275M
Average
0.567M
Median
2021
Revenue (Annual) Benchmarks
| Pfizer Inc | 58.50B |
| United Therapeutics Corp | 2.328B |
| Syndax Pharmaceuticals Inc | -- |
| Arcus Biosciences Inc | 117.00M |
| NovaBay Pharmaceuticals Inc | 14.73M |